Literature DB >> 9502410

Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma.

M Setoyama1, F A Kerdel, G Elgart, T Kanzaki, J J Byrnes.   

Abstract

A method for nonradioactive polymerase chain reaction in situ hybridization was developed and used to determine the distribution of human T-lymphotropic virus type I (HTLV-I) proviral DNA in paraffin-embedded surgical specimens of adult T-cell leukemia/lymphoma (ATLL). As controls, we used biopsy samples of five cases of mycosis fungoides, cells of an HTLV-I-infected cell line (MT2), as well as HTLV-1-negative cells (YAS). We successfully detected the amplicon of the HTLV-1 tax sequence in the nuclei of the cutaneous infiltrating lymphoid cells in 90% (9/10) of ATLL cases. Studies also revealed the existence of HTLV-1 provirus DNA in nuclei of sweat gland epithelial cells and vascular endothelial cells as well as lymphoid cells in ATLL patients. Mycosis fungoides and YAS cells were negative for the HTLV-I tax sequence, but MT2 cells were strongly positive. The results indicated that this technique was more sensitive in detecting intracellular amplicons than was the previous in situ hybridization method. Through its use, we were able to easily determine the distribution of HTLV-I-positive cells among the various cells and tissues of paraffin-embedded archival materials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502410      PMCID: PMC1858394     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  An improved technique for the in situ detection of DNA after polymerase chain reaction amplification.

Authors:  G J Nuovo; F Gallery; P MacConnell; J Becker; W Bloch
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

2.  Chronic inflammatory arthropathy associated with HTLV-I.

Authors:  K Nishioka; I Maruyama; K Sato; I Kitajima; Y Nakajima; M Osame
Journal:  Lancet       Date:  1989-02-25       Impact factor: 79.321

3.  Sjögren's syndrome with specific cutaneous manifestations and multifocal clonal T-cell populations progressing to a cutaneous pleomorphic T-cell lymphoma.

Authors:  P G van der Valk; H Hollema; P C van Voorst Vander; M G Brinker; S Poppema
Journal:  Am J Clin Pathol       Date:  1989-09       Impact factor: 2.493

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis.

Authors:  K Nakada; K Yamaguchi; S Furugen; T Nakasone; K Nakasone; Y Oshiro; M Kohakura; Y Hinuma; M Seiki; M Yoshida
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

6.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

7.  Retrovirus-like sequences in Graves' disease: implications for human autoimmunity.

Authors:  A Ciampolillo; V Marini; R Mirakian; M Buscema; T Schulz; R Pujol-Borrell; G F Bottazzo
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

8.  Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

Authors:  M Shimoyama
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

9.  The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group.

Authors:  K Tajima
Journal:  Int J Cancer       Date:  1990-02-15       Impact factor: 7.396

10.  Infective dermatitis of Jamaican children: a marker for HTLV-I infection.

Authors:  L LaGrenade; B Hanchard; V Fletcher; B Cranston; W Blattner
Journal:  Lancet       Date:  1990-12-01       Impact factor: 79.321

View more
  8 in total

1.  Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system.

Authors:  I A Romero; M C Prevost; E Perret; P Adamson; J Greenwood; P O Couraud; S Ozden
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.

Authors:  Gabriela Gualco; Lucimara Chioato; Lawrence M Weiss; William J Harrington; Carlos E Bacchi
Journal:  Am J Clin Pathol       Date:  2009-07       Impact factor: 2.493

Review 3.  Current concepts regarding the HTLV-1 receptor complex.

Authors:  David Ghez; Yves Lepelletier; Kathryn S Jones; Claudine Pique; Olivier Hermine
Journal:  Retrovirology       Date:  2010-11-29       Impact factor: 4.602

4.  Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.

Authors:  Hiroo Hoshino
Journal:  Front Microbiol       Date:  2012-06-21       Impact factor: 5.640

5.  RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia/lymphoma.

Authors:  Amir Farmanbar; Robert Kneller; Sanaz Firouzi
Journal:  NPJ Genom Med       Date:  2019-05-06       Impact factor: 8.617

6.  Alteration of blood-brain barrier integrity by retroviral infection.

Authors:  Philippe V Afonso; Simona Ozden; Marie-Christine Cumont; Danielle Seilhean; Luis Cartier; Payam Rezaie; Sarah Mason; Sophie Lambert; Michel Huerre; Antoine Gessain; Pierre-Olivier Couraud; Claudine Pique; Pierre-Emmanuel Ceccaldi; Ignacio A Romero
Journal:  PLoS Pathog       Date:  2008-11-14       Impact factor: 6.823

7.  High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status.

Authors:  Renata Okajima; Augusto C P Oliveira; Jerusa Smid; Jorge Casseb; Jose Antonio Sanches
Journal:  PLoS Negl Trop Dis       Date:  2013-11-07

8.  Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine.

Authors:  Maria Omsland; Cynthia Pise-Masison; Dai Fujikawa; Veronica Galli; Claudio Fenizia; Robyn Washington Parks; Bjørn Tore Gjertsen; Genoveffa Franchini; Vibeke Andresen
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.